// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Electrocardiogram Abnormalities Related to Antimalarials in Systemic Lupus Erythematosus

Taneisha McGhie - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Electronic Patient Reported Outcomes Increase Pediatric Rheumatology Clinic Operations Efficiency While Increasing Patient and Caregiver Satisfaction

Y. Ingrid Goh - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome

Samar Alharbi - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Etanercept (Enbrel®) Treatment Retention in the Sub-Population of Pediatric Patients from a Retrospective Cohort Study Using Canadian Claims-Level Data

Majed M M Khraishi - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Etanercept

Ethnic Variation in Systemic Sclerosis Morbidity and Mortality

Sindhu Johnson - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Evaluation of Synovial Fluid 14-3-3η Protein As a Marker of Joint Damage in Rheumatoid Arthritis Patients

Nevin Hammam - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Experiences and Perceptions of Patients with Rheumatoid Arthritis Participating in an Online Support Group: The Use of Social Media

Jude K. A. des Bordes - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Exploring Determinants Predicting Response to Intra-Articular Hyaluronic Acid Treatment in Symptomatic Knee Osteoarthritis

Jean-Pierre Pelletier - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

N/A

Hyaluronic acid

Exposure to Fine Particle Air Pollution and Anti-Nuclear Antibodies (ANA) in a Large Population-Based Sample

Sasha Bernatsky - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Extracutaneous Involvement Is Common in Juvenile Localized Scleroderma and Associated with a Higher Level of Perceived Disease Impact

Suzanne C. Li - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Factor Structure and Convergent Validity of the Derriford Appearance Scale-24 Using Standard Scoring Versus Treating “Not Applicable” Responses As Missing Data: A Scleroderma Patient-Centered Intervention Network Cohort Study

Erin L. Merz - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Factors Associated with Disease Progression in Early-Diagnosed Pulmonary Arterial Hypertension Associated with Systemic Sclerosis

Carina Mihai - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Factors Associated with Opioid Use in End-Stage Knee, Hip and Spine Osteoarthritis

J. Denise Power - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Epimorph

Favourable Changes in Power Doppler Scores in the Feet over 1-Year in an Early Rheumatoid Arthritis Cohort: The Role of Rheumatoid Factor and Anti–Citrullinated Protein Antibody

Karen A. Beattie - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

FLARE-RA Instrument Detects RA Flares Independent of Disease Activity

Taysir G. Mahmoud - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Frailty and Risk of Fractures in Patients with Rheumatoid Arthritis: Data from the Ontario Best Practices Research Initiative (OBRI)

Guowei Li - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Function, Pain, Fatigue, and Participation Are the Primary Contributors to the Patient Global Assessment in Rheumatoid Arthritis

Ethan Craig - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Gene Expression in Cellular Subsets in Psoriatic Disease

Anastasiya Muntyanu - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Generation of an Efficient CRISPR-Cas9 Editing Technique in Human Primary B Cells for the Targeted Study of Autoimmune Susceptibility Genes

Yuriy Baglaenko - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Genetic Phenotypes Impacting Efficacy and Safety of Canakinumab in Patients with Colchicine-Resistant FMF, TRAPS and Hids/Mkd: Results from Cluster Study

Fabrizio De Benedetti - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

canakinumab (SC)

Copyright © 2026. QuantiNova All rights reserved